Moderna | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Moderna, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2010. The company specializes in messenger RNA (mRNA) technology to develop medicines and vaccines for a wide range of conditions, including infectious diseases, cancer, and rare genetic disorders. Initially named ModeRNA Therapeutics, Moderna became globally recognized for its COVID-19 vaccine, mRNA-1273, which received emergency use authorization in December 2020.

Moderna leverages its innovative mRNA platform to accelerate the development of vaccines and therapeutics by enabling cells to produce therapeutic proteins. Its pipeline includes candidate treatments for diseases such as influenza, Zika, personalized cancer vaccines in partnership with Merck, and therapies for rare conditions like cystic fibrosis. With manufacturing facilities in Massachusetts and collaborations with pharmaceutical companies and agencies, Moderna continues to expand its research capabilities and therapeutic offerings.